Avidity Biosciences is a biotech company pioneering oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC). Its therapies are designed to overcome the current limitations of oligonucleotide therapies in order to treat a range of serious diseases. The company utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases.
|HQ||La Jolla, CA, US||Map|
Net income (FY, 2020)
EBIT (FY, 2020)
Market capitalization (22-Jul-2021)
Closing stock price (22-Jul-2021)
When was Avidity Biosciences founded?
Avidity Biosciences was founded in 2013.
Who are Avidity Biosciences key executives?
Avidity Biosciences's key executives are Joseph Baroldi, Arthur A. Levin and Michael MacLean.
How many employees does Avidity Biosciences have?
Avidity Biosciences has 38 employees.
What is Avidity Biosciences revenue?
Latest Avidity Biosciences annual revenue is $6.8 m.
What is Avidity Biosciences revenue per employee?
Latest Avidity Biosciences revenue per employee is $178.6 k.
Who are Avidity Biosciences competitors?
Competitors of Avidity Biosciences include Argenx, Lupin and Galapagos.
Where is Avidity Biosciences headquarters?
Avidity Biosciences headquarters is located at 10975 N Torrey Pines Rd #150, La Jolla.
Where are Avidity Biosciences offices?
Avidity Biosciences has an office in La Jolla.
How many offices does Avidity Biosciences have?
Avidity Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies